One of these major problems is that there is currently little to no pressure to bring down the list prices of drugs. A list price for a drug is sort of like the sticker price on a car. Sometimes it is a 50 percent cut to the list price, or more. This means PBMs benefit from higher list prices, since it allows them to negotiate steeper discounts. Along with Health and Human Services Secretary Alex Azar, President Trump deserves praise for releasing a serious and thoughtful plan to tackle high drug prices.

Source: Fox News May 16, 2018 15:00 UTC